HLDA-212
HLDA-212 is a non-covalent RIPTAC that targets FKBP (target protein, TP) and multiple CDK (effector protein, EP). HLDA-212 binds to FKBP and CDK to form a stable ternary complex (TP:RIPTAC:EP), and induces cell death by blocking FKBP function. HLDA-212 selectively inhibits the proliferation of CDK-expressing cells and accumulates in CDK-expressing cells in a CDK-dependent manner. HLDA-212 exhibits antiproliferative activity in 293_HFL cells (with a GI50 of 0.011 μM). HLDA-212 holds promise for the treatment of cancers with high FKBP expression.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 3077339-88-6
- 分子式: C70H90BrFN8O19S
- 分子量:1478.47
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
IC50 & Target
|
Aurora A |
Aurora B |
体外実験
HLDA-212 (Compound 43) (7 days; or 4 hours, followed by 7 days of cultivation without compound) selectively inhibits the proliferation of TP-expressing 293_HFL cells with a GI50 of 0.011 μM, showing a >900-fold greater potency than in TP-absent 293_GFPL cells[1].
HLDA-212 accumulates specifically in TP-expressing 293_HFL cells in a target protein-dependent manner[1].
HLDA-212 has reduced anti-proliferative potency in 293_MYRHF cells expressing plasma membrane-localized TP, indicating dependence on subcellular localization of target and effector proteins[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
CAS 番号 3077339-88-6
-
分子量 1478.47
-
分子式 C70H90BrFN8O19S
-
SMILES
CC[C@H](C(N1CCCC[C@H]1C(O[C@H](CCC2=CC=C(OC)C(OC)=C2)C3=CC=CC(OCC(N(C)CCOCCOCCOCCOCCOCCOCCNS(=O)(C4=CC=C(NC5=NC=C(Br)C(NC6=C(C(N)=O)C(F)=CC=C6)=N5)C=C4)=O)=O)=C3)=O)=O)C7=CC(OC)=C(OC)C(OC)=C7
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)